logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

SIPAI HEALTH (00314) spent HK$575,500 to buy back 229,400 shares on January 2nd.

date
19:36 02/01/2026
avatar
GMT Eight
Sino Group Health (00314) announced that on January 2, 2026, the company spent 575,500 Hong Kong dollars to repurchase 229,400 shares at a repurchase price of 2.46-2.53 Hong Kong dollars per share.
The announcement by SIPAI HEALTH (00314) states that on January 2, 2026, the company spent 575,500 Hong Kong dollars to repurchase 229,400 shares at a repurchase price of 2.46-2.53 Hong Kong dollars per share.
Related Articles
HK Stock
HUICHENG INTL H(01146): Shanghai Bi Rong, in which Qingdao Huaxin Anchors is invested, has successfully listed on the Hong Kong Stock Exchange.
New Stocks Outlook | Can Dragonext Semiconductor's move to Hong Kong from intelligent vision to AI and HPC open up a second growth curve?
HK Stock
CRMI (08158) intends to form a strategic partnership with China Star and acquire 55% of Kangmei Zan's shares.
HUICHENG INTL H(01146): Shanghai Bi Rong, in which Qingdao Huaxin Anchors is invested, has successfully listed on the Hong Kong Stock Exchange.
HK Stock
New Stocks Outlook | Can Dragonext Semiconductor's move to Hong Kong from intelligent vision to AI and HPC open up a second growth curve?
CRMI (08158) intends to form a strategic partnership with China Star and acquire 55% of Kangmei Zan's shares.
HK Stock
RECOMMEND
Crossing 2025, Can The Year‑End Rally Extend To The Close? Review Of This Week’s Ten Brokerage Strategies
Crossing 2025, Can The Year‑End Rally Extend To The Close? Review Of This Week’s Ten Brokerage Strategies
icon
29/12/2025
IPO Fundraising Tops The World, A Review Of Ten Key Themes For Hong Kong Stocks In 2025
IPO Fundraising Tops The World, A Review Of Ten Key Themes For Hong Kong Stocks In 2025
icon
29/12/2025
Will The U.S. Market Maintain Its Global Leadership Beyond 2025?
Will The U.S. Market Maintain Its Global Leadership Beyond 2025?
icon
29/12/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.